[HTML][HTML] lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment

H Jin, W Du, W Huang, J Yan, Q Tang, Y Chen… - … Therapy-Nucleic Acids, 2021 - cell.com
Breast cancer is a malignant tumor that has a high mortality rate and mostly occurs in
women. Although significant progress has been made in the implementation of personalized …

An update on the role of long non-coding RNAs in the pathogenesis of breast cancer

S Ghafouri-Fard, KH Tamizkar, BM Hussen… - Pathology-Research and …, 2021 - Elsevier
Breast cancer is the most frequent female malignancy. This malignancy has diverse clinical
and molecular subtypes with different prognoses. Dysregulation of long non-coding RNAs …

[HTML][HTML] NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation …

Z Chen, Y Xie, H Luo, Y Song, T Que, R Hu… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
The prognosis of glioma is poor as its pathogenesis and mechanisms underlying cisplatin
chemoresistance remain unclear. Nucleosome assembly protein 1 like 1 (NAP1L1) is …

Paeoniflorin sensitizes breast cancer cells to tamoxifen by downregulating microRNA-15b via the FOXO1/CCND1/β-catenin axis

Y Wang, Q Wang, X Li, G Luo, M Shen… - Drug design …, 2021 - Taylor & Francis
Background Paeoniflorin (Pae) possesses anti-tumor activity in various malignancies.
However, it is unclear whether Pae plays a sensitizer role in breast cancer (BC) and the …

LncRNA OIP5-AS1 promotes breast cancer progression by regulating miR-216a-5p/GLO1

Z Wu, Y Liu, L Wei, M Han - Journal of Surgical Research, 2021 - Elsevier
Background Breast cancer is a familiar malignant tumor, which is a great threat to women's
life. Long noncoding RNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) has been …

[HTML][HTML] PSMC2/CCND1 axis promotes development of ovarian cancer through regulating cell growth, apoptosis and migration

D Zhu, J Huang, N Liu, W Li, L Yan - Cell Death & Disease, 2021 - nature.com
Ovarian cancer is known as one of the most common malignancies of the gynecological
system, whose treatment is still not satisfactory because of the unclear understanding of …

[HTML][HTML] lncRNA FGD5‑AS1 promotes breast cancer progression by regulating the hsa‑miR‑195‑5p/NUAK2 axis

K Fang, ZJ Xu, SX Jiang, DS Tang… - Molecular …, 2021 - spandidos-publications.com
Breast cancer is the second most prevalent cancer in women worldwide. Long non‑coding
RNAs (lncRNAs) have been identified as important regulators of tumorigenesis and tumor …

[HTML][HTML] RETRACTED ARTICLE: Targeting a novel LncRNA SNHG15/miR-451/c-Myc signaling cascade is effective to hamper the pathogenesis of breast cancer (BC) …

J Du, H Zhong, B Ma - Cancer Cell International, 2021 - Springer
Abstract Background To our knowledge, LncRNA SNHG15 exerted its tumor-promoting
effects to facilitate the development of breast cancer (BC), but there still needed more data to …

LINC01355 contributes to malignant phenotype of oral squamous cell carcinoma and cytotoxic T cell infiltration via activating Notch signaling pathway

C Zou, S Wu, H Wei, H Luo, Z Tang… - Journal of …, 2021 - Wiley Online Library
LINC01355 has been demonstrated to be dysregulated in several cancers. However, the
exact molecular function of LINC01355 in the pathogenesis of OSCC remains unstudied …

An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancer

N Dastmalchi, R Safaralizadeh… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Breast cancer (BC) is the most significant threat to women's life. To demonstrate
its molecular mechanisms, which results in BC progression, it is crucial to develop …